GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (OTCPK:BXPHF) » Definitions » Common Stock

BXPHF (Botanix Pharmaceuticals) Common Stock : $119.60 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Botanix Pharmaceuticals Common Stock?

Botanix Pharmaceuticals's quarterly common stock increased from Dec. 2023 ($80.29 Mil) to Jun. 2024 ($125.05 Mil) but then declined from Jun. 2024 ($125.05 Mil) to Dec. 2024 ($119.60 Mil).

Botanix Pharmaceuticals's annual common stock increased from Jun. 2022 ($50.23 Mil) to Jun. 2023 ($62.75 Mil) and increased from Jun. 2023 ($62.75 Mil) to Jun. 2024 ($125.05 Mil).


Botanix Pharmaceuticals Common Stock Historical Data

The historical data trend for Botanix Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Common Stock Chart

Botanix Pharmaceuticals Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.29 54.65 50.23 62.75 125.05

Botanix Pharmaceuticals Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.66 62.75 80.29 125.05 119.60

Botanix Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Botanix Pharmaceuticals Business Description

Traded in Other Exchanges
Address
41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals Headlines